Literature DB >> 4549325

Gentamicin: toxicity in perspective.

W L Hewitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4549325

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  23 in total

1.  Renal extraction of gentamicin in anesthetized dogs.

Authors:  P J Chiu; A Brown; G Miller; J F Long
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

2.  Fanconi syndrome after ifosfamide.

Authors:  M Moncrieff; A Foot
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Gentamicin nephrotoxicity--morphologic and pharmacologic features.

Authors:  W M Bennet; D N Gilbert; D Houghton; G A Porter
Journal:  West J Med       Date:  1977-01

4.  Incidence of potentially toxic concentrations of gentamicin in the neonate.

Authors:  A Mulhall; J de Louvois; R Hurley
Journal:  Arch Dis Child       Date:  1983-11       Impact factor: 3.791

5.  A model for the prospective identification of the prenephrotoxic state during gentamicin therapy.

Authors:  W A Colburn; J J Schentag; W J Jusko; M Gibaldi
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

Review 6.  The pharmacological role of the kidney.

Authors:  D C Brater
Journal:  Drugs       Date:  1980-01       Impact factor: 9.546

Review 7.  Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.

Authors:  P Noone
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

Review 8.  Why monitor serum levels of gentamicin?

Authors:  M Barza; M Lauermann
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

9.  Statistical metamodeling for revealing synergistic antimicrobial interactions.

Authors:  Hsiang Chia Chen; Chia Hsiang Chen; Vincent Gau; Donna D Zhang; Joseph C Liao; Fei-Yue Wang; Pak Kin Wong
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

10.  Netilmicin: clinical efficacy, tolerance, and toxicity.

Authors:  A P Panwalker; J B Malow; V M Zimelis; G G Jackson
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.